2.33

1.69% -0.03

Oramed Pharmaceuticals Inc (ORMP)

Überblick Nachrichten Preisverlauf Optionskette Financials Forum Prognose Aktiensplit

Schlusskurs vom Vortag:

$2.36

Offen:

$2.35

24-Stunden-Volumen:

158.72K

Relative Volume:

1.49

Marktkapitalisierung:

$95.54M

Einnahmen:

$2.70M

Nettoeinkommen (Verlust:

$5.53M

KGV:

21.18

EPS:

0.11

Netto-Cashflow:

$-10.55M

1W Leistung:

-1.69%

1M Leistung:

-4.92%

6M Leistung:

+0.00%

1J Leistung:

-2.93%

1-Tages-Spanne:

$2.30

$2.40

1-Wochen-Bereich:

$2.29

$2.42

52-Wochen-Spanne:

$1.82

$3.09

Oramed Pharmaceuticals Inc Stock (ORMP) Company Profile

Firmenname

Oramed Pharmaceuticals Inc

Sektor

Healthcare (1141)

Branche

Biotechnology (633)

Telefon

646-844-1164

Adresse

1185 AVENUE OF THE AMERICAS, 3RD FLOOR, NEW YORK, NY

Mitarbeiter

Twitter

@OramedPharma

Nächster Verdiensttermin

2025-08-19

Neueste SEC-Einreichungen

ORMP's Discussions on Twitter

Vergleichen Sie ORMP mit anderen Aktien

Aktien	Preis	Marktkapitalisierung	Umsatz	Nettogewinn	Free Cashflow	ENV
ORMP Oramed Pharmaceuticals Inc	2.33	96.77M	2.70M	5.53M	-10.55M	0.11
VRTX Vertex Pharmaceuticals Inc	427.48	109.22B	11.39B	3.64B	3.50B	13.99
REGN Regeneron Pharmaceuticals Inc	633.37	67.50B	14.25B	4.58B	3.88B	41.77
ALNY Alnylam Pharmaceuticals Inc	427.20	57.35B	3.21B	43.57M	221.36M	0.2405
ARGX Argen X Se Adr	843.29	50.87B	3.06B	1.28B	447.35M	19.67
INSM Insmed Inc	185.65	39.72B	447.02M	-1.18B	-868.57M	-6.1812

Oramed Pharmaceuticals Inc Stock (ORMP) Upgrades & Downgrades

Datum	Aktion	Analytiker	Ratingänderung
2023-01-12	Herabstufung	Canaccord Genuity	Buy → Hold
2022-02-18	Eingeleitet	Cantor Fitzgerald	Overweight
2021-04-20	Eingeleitet	Canaccord Genuity	Buy
2021-02-09	Eingeleitet	National Securities	Buy
2020-12-03	Eingeleitet	Alliance Global Partners	Buy
2020-03-11	Eingeleitet	Aegis Capital	Buy
2019-09-11	Eingeleitet	Ladenburg Thalmann	Buy
2017-12-11	Fortgesetzt	B. Riley FBR, Inc.	Buy
2016-05-26	Bestätigt	FBR Capital	Outperform
2015-12-01	Bestätigt	H.C. Wainwright	Buy
2015-11-19	Eingeleitet	FBR Capital	Outperform
2015-04-13	Fortgesetzt	MLV & Co	Buy
2014-01-30	Bestätigt	Aegis Capital	Buy
2014-01-08	Bestätigt	Aegis Capital	Buy
2014-01-08	Eingeleitet	MLV & Co	Buy
2013-12-03	Eingeleitet	Aegis Capital	Buy

Alle ansehen

Oramed Pharmaceuticals Inc Aktie (ORMP) Neueste Nachrichten

07:13 AM

Ranking Oramed Pharmaceuticals Inc. among high performing stocks via tools - newser.com

07:13 AM

04:33 AM

Will Oramed Pharmaceuticals Inc. benefit from macro trendsWeekly Trade Report & High Yield Equity Trading Tips - newser.com

04:33 AM

02:53 AM

When is the best time to exit Oramed Pharmaceuticals Inc.July 2025 Recap & Entry Point Confirmation Signals - newser.com

02:53 AM

02:37 AM

Will Oramed Pharmaceuticals Inc. (OJU1) stock maintain strong growthCEO Change & Reliable Price Action Trade Plans - newser.com

02:37 AM

01:12 AM

Is Oramed Pharmaceuticals Inc. (OJU1) stock resilient in recession scenariosMarket Sentiment Report & Short-Term High Return Strategies - newser.com

01:12 AM

Nov 03, 2025

Why Oramed Pharmaceuticals Inc. stock is a must watch in 2025July 2025 Retail & Fast Entry High Yield Tips - newser.com

Nov 03, 2025

Oramed Pharmaceuticals Inc expected to post a loss of 19 cents a shareEarnings Preview - TradingView

Nov 03, 2025

Applying sector rotation models to Oramed Pharmaceuticals Inc.Index Update & Free Technical Confirmation Trade Alerts - newser.com

Nov 03, 2025

Is Oramed Pharmaceuticals Inc. stock a top pick in earnings seasonJuly 2025 EndofMonth & Weekly Momentum Stock Picks - newser.com

Nov 03, 2025

Published on: 2025-11-03 08:06:45 - newser.com

Nov 03, 2025

Will Oramed Pharmaceuticals Inc. stock continue upward momentumJuly 2025 Closing Moves & Weekly Setup with ROI Potential - newser.com

Nov 03, 2025

How Oramed Pharmaceuticals Inc. (OJU1) stock correlates with oil markets2025 Top Decliners & Entry Point Confirmation Alerts - newser.com

Nov 03, 2025

What sentiment indicators say about Oramed Pharmaceuticals Inc. stockWeekly Investment Report & Community Trade Idea Sharing - newser.com

Nov 03, 2025

What does recent volatility data suggest for Oramed Pharmaceuticals Inc.July 2025 Update & Trade Opportunity Analysis - newser.com

Nov 03, 2025

Published on: 2025-11-03 04:30:55 - newser.com

Nov 03, 2025

Published on: 2025-11-03 03:48:35 - newser.com

Nov 03, 2025

Can technical indicators confirm Oramed Pharmaceuticals Inc.’s reversalDollar Strength & Real-Time Buy Signal Alerts - newser.com

Nov 03, 2025

Using Ichimoku Cloud for Oramed Pharmaceuticals Inc. technicalsDay Trade & Precise Buy Zone Tips - newser.com

Nov 03, 2025

Visualizing Oramed Pharmaceuticals Inc. stock with heatmaps2025 Year in Review & Reliable Entry Point Trade Alerts - newser.com

Nov 03, 2025

Is Oramed Pharmaceuticals Inc. (OJU1) stock ideal for retirement investorsWeekly Trade Report & Low Risk High Reward Trade Ideas - newser.com

Nov 03, 2025

What insider trading reveals about Oramed Pharmaceuticals Inc. stockJuly 2025 EndofMonth & Reliable Volume Spike Alerts - newser.com

Nov 03, 2025

Pattern recognition hints at Oramed Pharmaceuticals Inc. upside2025 Volume Leaders & Weekly Momentum Picks - newser.com

Nov 03, 2025

Why Oramed Pharmaceuticals Inc. (OJU1) stock fits value portfolios2025 Risk Factors & Growth-Oriented Investment Plans - newser.com

Nov 03, 2025

Nov 02, 2025

Is Oramed Pharmaceuticals Inc a good long term investmentMoving Average Strategies & Superior Growth Investment - earlytimes.in

Nov 02, 2025

Is Oramed Pharmaceuticals Inc. stock a defensive play in 20252025 Geopolitical Influence & Community Consensus Trade Signals - newser.com

Nov 02, 2025

What recovery options are there for Oramed Pharmaceuticals Inc.Short Setup & Real-Time Volume Analysis Alerts - newser.com

Nov 02, 2025

How Oramed Pharmaceuticals Inc. stock reacts to global recession fearsMarket Activity Report & Weekly Chart Analysis and Guides - newser.com

Nov 02, 2025

Oramed Pharmaceuticals (NASDAQ:ORMP) Rating Increased to Hold at Wall Street Zen - MarketBeat

Nov 02, 2025